News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Shaalan Beg: Poll Insights on BREAKWATER Trial Results
Shaalan Beg/cancercommons.org
Feb 1, 2025, 07:52

Shaalan Beg: Poll Insights on BREAKWATER Trial Results

Shaalan Beg, Senior Advisor for Clinical Research at the National Cancer Institute, posted the following on X:

“Interesting insights from our poll on the BREAKWATER trial results. Nearly a quarter of respondents will wait for final OS data before offering Enco+Cetux_FOLFOX routinely for newly diagnosed BRAFV600E mutated CRC.”

Shaalan Beg: Poll Insights on BREAKWATER Trial Results

BRAF mutation BRAFV600E BREAKWATER trial cancer Cancer Management Clinical Decision Making clinical trial outcomes colorectal cancer CRC treatment Enco+Cetux_FOLFOX FOLFOX OncoDaily Oncology oncology research patient care Phase 3 Trial poll results Shaalan Beg survival data targeted therapy Treatment Strategies
Special Coverage
Insight
Sep 4, 2025, 20:03
Aruni Ghose: AI-Enhanced Medical Imaging for Cancer Diagnosis
Insight
Sep 4, 2025, 19:35
A Reminder That Education Is Essential to Patient Care - Elekta
Dialogues
Sep 4, 2025, 18:19
MASCC 2025 Presidential Training Fellowship Spotlight: Dr. Colleen Ann Cuthbert
Immune Oncology
Sep 4, 2025, 16:49
LIBRETTO-431 East Asia Subgroup Results of First-line Selpercatinib vs Chemotherapy + Pembrolizumab in RET Fusion–Positive NSCLC
OncoDaily Pulse
Sep 4, 2025, 16:17
Mariam Sargsyan: Meet the Experts of VIRO 2025
OncoDaily Pulse
Sep 4, 2025, 16:08
Elizabeth Wulff-Burchfield: Meet the Experts of VIRO 2025
Voices
Sep 4, 2025, 15:59
Markus Kosch: Finding Strength After Diagnosis - A Conversation with Claudia Poguntke
Voices
Sep 4, 2025, 15:59
Common Sense Oncology India Hub Webinar – Insights on the MATTERHORN Trial
Voices
Sep 4, 2025, 15:56
Servier and IDEAYA Biosciences Partner to Advance Darovasertib for Uveal Melanoma
Voices
Sep 4, 2025, 15:55
Bridging Divides, Building Futures at the 2025 World Cancer Leaders’ Summit - UICC
Insight
Sep 4, 2025, 15:51
Christine Maheu: Systematic Review of Fear of Cancer Recurrence Measures 
Voices
Sep 4, 2025, 15:49
Svetlana Nikic: My Journey in Precision Oncology